1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41408-017-0030-y
DC FieldValue
dc.titleOutcomes of patients with peripheral t-cell lymphoma in first complete remission: Data from three tertiary asian cancer centers
dc.contributor.authorTang, T
dc.contributor.authorKhoo, L.P
dc.contributor.authorLim, C
dc.contributor.authorHam, J.S
dc.contributor.authorKim, S.J
dc.contributor.authorHong, H
dc.contributor.authorPhipps, C
dc.contributor.authorLee, Y.S
dc.contributor.authorTao, M
dc.contributor.authorQuek, R
dc.contributor.authorFarid, M
dc.contributor.authorLin, T
dc.contributor.authorKim, W.S
dc.contributor.authorLim, S.T
dc.date.accessioned2020-10-20T10:16:59Z
dc.date.available2020-10-20T10:16:59Z
dc.date.issued2017
dc.identifier.citationTang, T, Khoo, L.P, Lim, C, Ham, J.S, Kim, S.J, Hong, H, Phipps, C, Lee, Y.S, Tao, M, Quek, R, Farid, M, Lin, T, Kim, W.S, Lim, S.T (2017). Outcomes of patients with peripheral t-cell lymphoma in first complete remission: Data from three tertiary asian cancer centers. Blood Cancer Journal 7 (12) : 653. ScholarBank@NUS Repository. https://doi.org/10.1038/s41408-017-0030-y
dc.identifier.issn2044-5385
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/178552
dc.description.abstract[No abstract available]
dc.publisherNature Publishing Group
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectalemtuzumab
dc.subjectanthracycline
dc.subjectcarboplatin
dc.subjectcisplatin
dc.subjectcytarabine
dc.subjectetoposide
dc.subjectgemcitabine
dc.subjectifosfamide
dc.subjectmethotrexate
dc.subjectprocarbazine
dc.subjectsteroid
dc.subjectvincristine
dc.subjectantineoplastic agent
dc.subjectadolescent
dc.subjectadult
dc.subjectaged
dc.subjectallogeneic stem cell transplantation
dc.subjectanaplastic large cell lymphoma
dc.subjectangioimmunoblastic t cell lymphoma
dc.subjectcancer center
dc.subjectcancer combination chemotherapy
dc.subjectcancer patient
dc.subjectcancer prognosis
dc.subjectcancer regression
dc.subjectcancer survival
dc.subjectcancer therapy
dc.subjectclinical outcome
dc.subjectcohort analysis
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectdrug megadose
dc.subjectfemale
dc.subjecthuman
dc.subjectInternational Prognostic Index
dc.subjectintestine lymphoma
dc.subjectLetter
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectmonomorphic epitheliotropic intestinal T cell lymphoma
dc.subjectoverall survival
dc.subjectperipheral T cell lymphoma
dc.subjectprogression free survival
dc.subjectretrospective study
dc.subjectvery elderly
dc.subjectAsian continental ancestry group
dc.subjectdisease free survival
dc.subjectinduction chemotherapy
dc.subjectKaplan Meier method
dc.subjectmortality
dc.subjectpathology
dc.subjectperipheral T cell lymphoma
dc.subjectproportional hazards model
dc.subjectremission
dc.subjectrisk factor
dc.subjecttreatment outcome
dc.subjectAdult
dc.subjectAged
dc.subjectAntineoplastic Combined Chemotherapy Protocols
dc.subjectAsian Continental Ancestry Group
dc.subjectDisease-Free Survival
dc.subjectFemale
dc.subjectHumans
dc.subjectInduction Chemotherapy
dc.subjectKaplan-Meier Estimate
dc.subjectLymphoma, T-Cell, Peripheral
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectProportional Hazards Models
dc.subjectRemission Induction
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectTreatment Outcome
dc.typeLetter
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1038/s41408-017-0030-y
dc.description.sourcetitleBlood Cancer Journal
dc.description.volume7
dc.description.issue12
dc.description.page653
dc.published.statepublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41408-017-0030-y.pdf255.34 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons